MedPath

Effect of treatment program on pain, function and disability in type 2 Diabetic individuals with long term low back pai

Not Applicable
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Registration Number
CTRI/2023/03/050346
Lead Sponsor
Spry Therapeutics Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Phase I: Age 18 to 65 years, participants diagnosed with T2DM and on medication from past 1 year, T2DM with or without peripheral neuropathy, HbA1c > 6.4%

Phase II: Age 18 to 65 years, history of low back pain LBP > 3 months, Participants diagnosed with Type 2 Diabetes Mellitus and on medication from past 1 year, HbA1c > 6.4%, Numeric pain rating scale >3, Oswestry disability index Score >20%.

Exclusion Criteria

Phase I: Infections or tumors of the spine, systemic bone or joint disorders, neuromuscular pathology, presence of a diagnosed severe psychiatric disorder, confirmed pregnancy, acute disc prolapse, prolapsed Intervertebral disc of other causes, low back pain due to traumatic causes

Phase II: Infections or tumors of the spine, systemic bone or joint disorders, unstable

cardiovascular and pulmonary diseases, polyneuropathies and musculoskeletal system diseases, presence of a diagnosed severe psychiatric disorder, confirmed pregnancy, any systemic complications which prevents their participation in study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢ Pressure pain Threshold using algometer <br/ ><br>â?¢ Gait analysis using Win-track <br/ ><br>â?¢ Pain using Numeric pain rating scaleTimepoint: Before start of the intervention, at 12 weeks and at 24 weeks after that
Secondary Outcome Measures
NameTimeMethod
â?¢ Disability using Oswestry disability index <br/ ><br>â?¢ Soft tissue changes using MRI of low backTimepoint: Before start of the intervention, at 12 weeks and at 24 weeks after that
© Copyright 2025. All Rights Reserved by MedPath